Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO

December 21, 2010 3:33 am | by RealWire | News | Comments

PHILADELPHIA, PA, 21 December 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is...

Advanced Laser Therapy Solutions for Women's Hair Loss

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Many Women suffering from hair loss are turning to Advanced Hair Studio s and discovering advanced laser therapy as a method along with other procedures to overcome thinning hair. This method of hair restoration has been shown to be affective in helping a woman's...

Silence Therapeutics Provides Year-end Update

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today...

Advertisement

Stem Cells Made with RNA

December 20, 2010 8:34 pm | by Massachusetts Institute of Technology | News | Comments

A new technique could provide safer cells for human therapies

Breakthrough in TB Diagnostics

December 20, 2010 8:33 pm | by Massachusetts Institute of Technology | News | Comments

A rapid genetic test for tuberculosis could have a huge impact on global health.

Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors

December 20, 2010 12:33 pm | by Boston Scientific | News | Comments

NATICK, Mass., Dec. 20, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Kristina M. Johnson, Ph.D., as a Director, effective January 1

The Center for Business Intelligence (CBI) Receives Top 100 Women-Led Businesses Award

December 20, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

WOBURN, Mass., Dec. 20, 2010 /- The Center for Business Intelligence (CBI) has been recognized as a Top 100 Women-Led Business in Massachusetts in 2009. The honor was awarded recently to Kathleen Y. Coffey, CBI President, by the Boston Business Journal and The Commonwealth Institute at...

FDA CONSUMER HEALTH INFORMATION - Generic Drug Roundup: December 2010

December 20, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Dec. 20, 2010 /PRNewswire-USNewswire/ -- Each year, the Food and Drug Administration (FDA) approves many generic drugs that treat a wide variety of conditions and help consumers save money. To read about recent significant FDA approvals for generic medications, go to...

Advertisement

PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia

December 20, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Dec. 20, 2010 /- PharMEDium Services LLC, announced the addition of Propofol to its custom operating room anesthesia syringe preparation services.  PharMEDium is the first compounder to offer Propofol in a pre-labeled, single patient, ready-to-use, tamper evident...

MinuteClinic Becomes First Retail Clinic Provider to Launch Partnership with National Patient Safety Foundation for Ask Me 3â„¢ Program

December 20, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Dec. 20, 2010 /- MinuteClinic, the pioneer and largest provider of retail-based medical clinics in the United States, has entered into an agreement with the National Patient Safety Foundation to become the nation's first retail clinic provider to implement the Ask Me 3...

New Software for Improving the Analysis of OCT Images

December 20, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

PINE BROOK, N.J., Dec. 20, 2010 /- Diopsys, Inc. today announced the development of software that uses existing Spectral Domain Optical Coherence Tomography (SD-OCT) images to assist ophthalmologists and optometrists in diagnosing retinal and optic nerve disease such as glaucoma.  ...

Sysmex America Announces Executive Promotions

December 20, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

MUNDELEIN, Ill., Dec. 20, 2010 /- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced two organizational changes that further position the company's North American subsidiary for continued growth and market leadership. John...

Finnish researchers find a compound that prevents the growth of prostate cancer cells

December 20, 2010 6:32 am | by EurekAlert | News | Comments

(VTT Technical Research Centre of Finland) Researchers from VTT Technical Research Centre of Finland and the University of Turku have demonstrated that an antibiotic called "monensin" prevents the growth of prostate cancer cells. Monensin is used in the meat and dairy industry, for example.

Advertisement

CareFusion Launches EnVe Ventilator, Weighing 10 Times Less Than Traditional Critical Care Ventilators

December 20, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 20, 2010 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today launched the EnVe™ ventilator , a high-performance critical care ventilator that weighs 9.5 pounds—about 70-80 pounds lighter than other ventilators with similar functions....

Varian Medical Systems Schedules First Quarter FY2011 News Release and Conference Call

December 20, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Dec. 20, 2010 /- Varian Medical Systems (NYSE: VAR ) announced today that it will report results for first quarter of fiscal year 2011 following the close of regular trading on Wednesday, January 26, 2011.  The news release will be followed by a teleconference...

Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy

December 20, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 20, 2010 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced that it has submitted the initial sections of a rolling submission for a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the use of metreleptin to treat diabetes...

Endologix Appoints Guido Neels to Its Board of Directors

December 20, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Dec. 20, 2010 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today that Guido Neels, Managing Director at Essex Woodlands Health Ventures, has joined the Endologix Board of Directors. Essex Woodlands was the...

HeartSine Technologies Wins 2010 Aisling Award for Outstanding Achievement in Business

December 20, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

BELFAST, Northern Ireland, Dec. 20, 2010 /- HeartSine Technologies received the Outstanding Achievement in Business Award at the 14th annual Aisling Awards ceremony, November 25th, in Belfast, Northern Ireland. The award honors an exemplary company who has made significant contributions...

St Helens & Knowsley Teaching Hospitals NHS Trust wins healthcare IT category at the 2010 Health Business Awards

December 20, 2010 3:37 am | by RealWire | News | Comments

The third award received this year for landmark electronic medical records project December 20, 2010 - C Cube Solutions and Kodak (NYSE:EK) today announce that Merseyside-based St Helens & Knowsley Teaching Hospitals NHS Trust has won the healthcare IT category at the 2010 Health...

Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)

December 20, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y. and BERLIN, Dec. 20, 2010 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) and Bayer HealthCare today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3...

Stereotaxis Completes $40 Million Credit Facility

December 20, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Dec. 20, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that the Company has closed on its previously announced $40 million credit facility, which includes a $30 million revolving facility that matures on March 31, 2012 and a $10 million term loan that matures on...

Federal Register: Defense Advanced Research Projects Agency and Food and Drug Administration Expanding In Vivo Biomarker Detection Devices Workshop(2)

December 20, 2010 3:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing the following public workshop cosponsored with the Defense Advanced Research Projects Agency (DARPA): Expanding In Vivo Biomarker Detection Devices Workshop.

Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study i...

December 19, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Dec. 20, 2010 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time on Monday, December 20, to discuss results of the Phase 3 COPERNICUS study with VEGF Trap-Eye in central retinal vein...

Expansion-Minded Biotech Looks to Locate Headquarters Locally

December 19, 2010 10:31 pm | by San Diego Business Journal | News | Comments

After being headquartered in two other cities in the space of three years, HemaQuest Pharmaceuticals Inc. is touching down in San Diego, a situation which brings the company - which is focusing on therapeutics to treat hemoglobin diseases - into the path of greater investment opportunity,...

La Jolla Institute's Work Might Prove Crucial to Drug Developers

December 19, 2010 10:31 pm | by San Diego Business Journal | News | Comments

Computer modeling could be giving some researchers a head start on how to better proceed in drug development.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading